.png)
.png)
MSCI Fully Affirmed Onehealth 100 and incorporated it into China’s A-share Index
【Date：2016.08.18 Source：】MSCI Fully Affirmed Onehealth 100 and incorporated it into China’s A-share Index
The latest season inspection index results released by Morgan Stanley Capital International Company (MSCI) show that China’s A-share index would incorporate 8 stocks after closing the transaction on August 31, including Onehealth 100, China Nuclear Construction, Linglong tires, etc.
Morgan Stanley Capital International Company (MSCI) was established in 1968, which the first provider for global benchmark supplier, index data and company information. China’s A-share index is the first independent state index that MSCI set up for China’s A-share market. Market analysts think that Onehealth 100 to be incorporated into A-share market will make international investors, especially institutional investors and long-term investors increase their attention to China securities market. On the whole, this will urge market mechanism of A-share to be geared to international standards and have stricter requirements with the liquidity, the perfection of supervision, etc. Moreover, it also has the role in promoting the perfection of A-share market system.
The enterprises that are incorporated into China’s A-share index scope should have the following characteristics: having the representativeness in its industry, a large scale and good liquidity, etc. Therefore, Onehealth 100 gets promoted as an enterprise entering MSCI’s China’s A-share index, which fully affirmed the representative position of Onehealth 100 in China’s health examination industry. Onehealth 100 developed rapidly in recent years and it realized great-leap-forward development through becoming the holding company of another physical examination giant Ciming. Finally, it successfully landed China’s A-share market in August of 2015. In 2015, Onehealth 100 (single) operating revenue and net profits took the first place in China’s physical examination industry, far ahead of the competitors in ht industry.
In 2016, Onehealth 100 continues to make persistent efforts and has purchased high-end physical examination center MJ Examination. Meanwhile, it extends its business to gene detection, medical big data, remote interpretation services. In July of 2016, Onehealth 100 became the first medical institution that cooperated with national level medical research center. This marks that, as the largest professional physical examination chain brand in China, Onehealth 100’s health big data accumulation gained the recognition from national level medical research center.
Onehealth 100 expressed, the company will concentrate its efforts on the enterprise strategy that takes two closed loops as the core. The first closed loop is to take the physical examination platform as the core, which extends from professional physical examination to individual prevention and accurate treatment, plus insurance and financial platform to form a closed loop; the second platform is innovation incubation platform, which hatches the top bio-medical technology on huge health big data platform. These two closed loops become increasingly powerful, which help to form an innovation system of medical industry based on powerful physical examination ecology.
